CBD has emerged as a non-psychoactive agent in cannabis, stimulating a boom of boutique cannabis products into the medicinal and adult use markets .

The innovative CannaMetrix EC50 Array™  offers a solution to traditional chemical methods of testing cannabis potency, which often fall short in accurately capturing the complex interactions between cannabinoids and the human body.

Find more at  https://cannametrix.org/

Read more in Research Outreach